CN101390854A - 一种含有利鲁唑的药用组合物 - Google Patents
一种含有利鲁唑的药用组合物 Download PDFInfo
- Publication number
- CN101390854A CN101390854A CN 200710122142 CN200710122142A CN101390854A CN 101390854 A CN101390854 A CN 101390854A CN 200710122142 CN200710122142 CN 200710122142 CN 200710122142 A CN200710122142 A CN 200710122142A CN 101390854 A CN101390854 A CN 101390854A
- Authority
- CN
- China
- Prior art keywords
- filler
- riluzole
- compositions according
- water
- composition weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
组分 重量百分比(%) |
利鲁唑 15.0淀粉 27.5山梨醇 48.0交联聚维酮 5.0羟丙甲基纤维素 2.5微粉硅胶 2.0Total 100 |
组分 重量百分比(%) |
利鲁唑 21.5微晶纤维素 27.0乳糖 40.0交联聚维酮 4.0交联聚维酮 4.0羟丙甲基纤维素 2.5硬脂酸镁 1.0Total 100 |
组分 重量百分比(%) |
利鲁唑 28.5磷酸氢钙 25.0微晶纤维素 35.0低取代羟丙基纤维素 6.5羟丙甲基纤维素 2.5硬脂酸镁 2.5Total 100 |
时间 5min 10min 20min 30min 45min 60min |
实施例3溶出度(%) 48.8 69.4 83.7 93.3 97.1 97.2实施例4溶出度(%) 40.1 55.3 75.2 88.1 90.2 91.1 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710122142 CN101390854A (zh) | 2007-09-21 | 2007-09-21 | 一种含有利鲁唑的药用组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710122142 CN101390854A (zh) | 2007-09-21 | 2007-09-21 | 一种含有利鲁唑的药用组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101390854A true CN101390854A (zh) | 2009-03-25 |
Family
ID=40491494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200710122142 Pending CN101390854A (zh) | 2007-09-21 | 2007-09-21 | 一种含有利鲁唑的药用组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101390854A (zh) |
Cited By (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013167993A1 (en) * | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurological degenerative disorders |
CN104606683A (zh) * | 2015-01-20 | 2015-05-13 | 北京福原环球生物科技有限公司 | 一种口腔崩解制剂 |
CN104684558A (zh) * | 2012-07-31 | 2015-06-03 | 耶达研究及发展有限公司 | 诊断和治疗运动神经元疾病的方法 |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
US9102649B1 (en) | 2014-09-29 | 2015-08-11 | Mahesh Kandula | Compositions and methods for the treatment of multiple sclerosis |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9174931B2 (en) | 2013-06-04 | 2015-11-03 | Cellix Bio Private Limited | Compositions for the treatment of diabetes and pre-diabetes |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9187427B2 (en) | 2012-08-03 | 2015-11-17 | Cellix Bio Private Limited | N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
US9227974B2 (en) | 2012-05-23 | 2016-01-05 | Cellex Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9303038B2 (en) | 2011-09-06 | 2016-04-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological diseases |
US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
US9315478B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9315461B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
US9346742B2 (en) | 2012-05-10 | 2016-05-24 | Cellix Bio Private Limited | Compositions and methods for the treatment of fibromyalgia pain |
US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
US9403857B2 (en) | 2012-05-10 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9434729B2 (en) | 2012-05-23 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
US9499527B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9498461B2 (en) | 2012-05-23 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
US9522884B2 (en) | 2012-05-08 | 2016-12-20 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic disorders |
US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
US9580383B2 (en) | 2012-05-23 | 2017-02-28 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9624168B2 (en) | 2012-09-06 | 2017-04-18 | Cellix Bio Private Limited | Compositions and methods for the treatment inflammation and lipid disorders |
US9642915B2 (en) | 2012-05-07 | 2017-05-09 | Cellix Bio Private Limited | Compositions and methods for the treatment of neuromuscular disorders and neurodegenerative diseases |
US9670153B2 (en) | 2012-09-08 | 2017-06-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammation and lipid disorders |
US9725404B2 (en) | 2014-10-27 | 2017-08-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9738631B2 (en) | 2012-05-07 | 2017-08-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9765020B2 (en) | 2012-05-23 | 2017-09-19 | Cellix Bio Private Limited | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis |
US9771355B2 (en) | 2014-09-26 | 2017-09-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US10227301B2 (en) | 2015-01-06 | 2019-03-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammation and pain |
CN111821289A (zh) * | 2020-02-27 | 2020-10-27 | 鲁南制药集团股份有限公司 | 一种利鲁唑口崩片及其制备方法 |
-
2007
- 2007-09-21 CN CN 200710122142 patent/CN101390854A/zh active Pending
Cited By (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9303038B2 (en) | 2011-09-06 | 2016-04-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological diseases |
US9738631B2 (en) | 2012-05-07 | 2017-08-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9642915B2 (en) | 2012-05-07 | 2017-05-09 | Cellix Bio Private Limited | Compositions and methods for the treatment of neuromuscular disorders and neurodegenerative diseases |
US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9522884B2 (en) | 2012-05-08 | 2016-12-20 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic disorders |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
WO2013167993A1 (en) * | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurological degenerative disorders |
US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
US9346742B2 (en) | 2012-05-10 | 2016-05-24 | Cellix Bio Private Limited | Compositions and methods for the treatment of fibromyalgia pain |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
US9499527B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
US9403857B2 (en) | 2012-05-10 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
US9315478B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9315461B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
US9434729B2 (en) | 2012-05-23 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
US9765020B2 (en) | 2012-05-23 | 2017-09-19 | Cellix Bio Private Limited | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis |
US9580383B2 (en) | 2012-05-23 | 2017-02-28 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9227974B2 (en) | 2012-05-23 | 2016-01-05 | Cellex Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
US9498461B2 (en) | 2012-05-23 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9403793B2 (en) | 2012-07-03 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US10159670B2 (en) | 2012-07-31 | 2018-12-25 | Yeda Research And Development Co. Ltd. | Methods of diagnosing and treating motor neuron diseases and other cellular stress-related diseases |
CN104684558A (zh) * | 2012-07-31 | 2015-06-03 | 耶达研究及发展有限公司 | 诊断和治疗运动神经元疾病的方法 |
US9187427B2 (en) | 2012-08-03 | 2015-11-17 | Cellix Bio Private Limited | N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases |
US9624168B2 (en) | 2012-09-06 | 2017-04-18 | Cellix Bio Private Limited | Compositions and methods for the treatment inflammation and lipid disorders |
US9670153B2 (en) | 2012-09-08 | 2017-06-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammation and lipid disorders |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
US9174931B2 (en) | 2013-06-04 | 2015-11-03 | Cellix Bio Private Limited | Compositions for the treatment of diabetes and pre-diabetes |
US9840472B2 (en) | 2013-12-07 | 2017-12-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of mucositis |
US9771355B2 (en) | 2014-09-26 | 2017-09-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
US9102649B1 (en) | 2014-09-29 | 2015-08-11 | Mahesh Kandula | Compositions and methods for the treatment of multiple sclerosis |
US9988340B2 (en) | 2014-09-29 | 2018-06-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9725404B2 (en) | 2014-10-27 | 2017-08-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
US10227301B2 (en) | 2015-01-06 | 2019-03-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammation and pain |
US10343994B2 (en) | 2015-01-06 | 2019-07-09 | Mahesh Kandula | Compositions and methods for the treatment of inflammation and pain |
CN104606683A (zh) * | 2015-01-20 | 2015-05-13 | 北京福原环球生物科技有限公司 | 一种口腔崩解制剂 |
CN104606683B (zh) * | 2015-01-20 | 2017-08-01 | 北京福原环球生物科技有限公司 | 一种口腔崩解制剂 |
CN111821289A (zh) * | 2020-02-27 | 2020-10-27 | 鲁南制药集团股份有限公司 | 一种利鲁唑口崩片及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101390854A (zh) | 一种含有利鲁唑的药用组合物 | |
CA2646667C (en) | Methods of treating hot flashes with formulations for transdermal or transmucosal application | |
FI2346495T4 (fi) | Farmaseuttinen formulaatio 514 | |
HU197840B (en) | Process for producing synergic pharmaceutical compositions comprising amantadin and selegilin | |
EP3417861A1 (en) | Pharmaceutical composition containing jak kinase inhibitor or pharmaceutically acceptable salt thereof | |
NZ595984A (en) | Production of encapsulated nanoparticles at commercial scale | |
FR2854074A1 (fr) | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques | |
AU2007251471A1 (en) | New form of administration of racecadotril | |
HU229502B1 (en) | Use of epinastine in the treatment of allergic rithinis/conjuctivitis | |
JP2005516904A5 (zh) | ||
WO2006103551A1 (en) | Controlled release formulations of oxycodone | |
JP2007529564A5 (zh) | ||
JP2019532112A5 (ja) | 結節性痒疹を治療するための抗掻痒剤 | |
KR19990077156A (ko) | 폐경기 증상의 치료 또는 예방을 위한 약학적 조성물의제조를 위한 3,4-디페닐크로만의 사용 | |
CA2531853A1 (en) | Pharmaceutical formulation comprising levothyroxine sodium | |
CN101548958B (zh) | 一种含有盐酸特比萘芬的分散片 | |
EA013262B1 (ru) | Пероральные твёрдые лекарственные формы, содержащие низкую дозу эстрадиола | |
JP2019509309A5 (zh) | ||
JPWO2008120562A1 (ja) | 帯状疱疹後神経痛治療用錠剤および帯状疱疹後神経痛の治療方法 | |
CN104434829A (zh) | 一种石菖蒲挥发油口腔速崩片及其制备方法 | |
CN108785263B (zh) | 普拉克索或其药用盐的固体药物组合物及其制备方法 | |
US20090142321A1 (en) | Opthalmic composition | |
CN1430956A (zh) | 一种治疗肠胃疾病的药物 | |
AR062894A1 (es) | Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths) | |
CN110025614A (zh) | 一种口腔护理组合物及其在治疗慢性口腔炎中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: VENTURE PHARMACEUTICAL (HAINAN) CO., LTD. Free format text: FORMER OWNER: DEZHONG WANQUAN PHARMACEUTICALS TECH. DEV. CO., LTD., BEIJING Effective date: 20110321 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100097 WANQUAN BUILDING, NO. 3, JINZHUANG, SIJIQING, HAIDIAN DISTRICT, BEIJING TO: 570314 NO. 279, NANHAI AVENUE, HAIKOU CITY |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110321 Address after: 570314 No. 279 Nanhai Road, Haikou Applicant after: Beijing D-Venturepharm Technology Development Co., Ltd. Address before: 100097 Beijing city Haidian District Sijiqing Wanquan Zhuang 3 Building Applicant before: Dezhong Wanquan Pharmaceuticals Tech. Dev. Co., Ltd., Beijing |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090325 |